Haemonetics (HAE) Shares Outstanding (2009 - 2026)

Haemonetics has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $45.5 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 5.58% year-over-year to $45.5 million in Q2 2026; TTM through Jun 2026 was $45.5 million, a 5.58% decrease from a year earlier, with the FY2026 full-year figure at $45.3 million, down 6.15% from the prior year.
• Shares Outstanding (Entity) was $45.5 million for Q2 2026 at Haemonetics, roughly flat from $45.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $51.3 million in Q3 2022, with the low at $45.3 million in Q1 2026.
• Average Shares Outstanding (Entity) over 5 years is $49.5 million, with a median of $50.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) gained 0.88% in 2024, then slipped 7.21% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $50.4 million in 2022, then climbed by 0.68% to $50.8 million in 2023, then decreased by 1.08% to $50.2 million in 2024, then fell by 6.78% to $46.8 million in 2025, then slipped by 2.9% to $45.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $45.5 million (Q2 2026), $45.3 million (Q1 2026), and $46.8 million (Q4 2025), per Business Quant data.